• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组包被受损限制了人细小病毒 B19 的体外增殖。

Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.

机构信息

Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.

出版信息

J Virol Methods. 2013 Oct;193(1):215-25. doi: 10.1016/j.jviromet.2013.06.003. Epub 2013 Jun 10.

DOI:10.1016/j.jviromet.2013.06.003
PMID:23764418
Abstract

The lack of a permissive cell culture system hampers the study of human parvovirus B19 (B19V). UT7/Epo is one of the few established cell lines that can be infected with B19V but generates none or few infectious progeny. Recently, hypoxic conditions or the use of primary CD36+ erythroid progenitor cells (CD36+ EPCs) have been shown to improve the infection. These novel approaches were evaluated in infection and transfection experiments. Hypoxic conditions or the use of CD36+ EPCs resulted in a significant acceleration of the infection/transfection and a modest increase in the yield of capsid progeny. However, under all tested conditions, genome encapsidation was impaired seriously. Further analysis of the cell culture virus progeny revealed that differently to the wild-type virus, the VP1 unique region (VP1u) was exposed partially and was unable to become further externalized upon heat treatment. The fivefold axes pore, which is used for VP1u externalization and genome encapsidation, might be constricted by the atypical VP1u conformation explaining the packaging failure. Although CD36+ EPCs and hypoxia facilitate B19V infection, large quantities of infectious progeny cannot be generated due to a failure in genome encapsidation, which arises as a major limiting factor for the in vitro propagation of B19V.

摘要

缺乏许可的细胞培养系统阻碍了人类细小病毒 B19(B19V)的研究。UT7/Epo 是少数几种可以被 B19V 感染但产生很少或几乎没有感染性后代的已建立细胞系之一。最近,缺氧条件或使用原代 CD36+红系祖细胞(CD36+EPC)已被证明可以改善感染。这些新方法在感染和转染实验中进行了评估。缺氧条件或使用 CD36+EPC 可显著加速感染/转染,并适度增加衣壳后代的产量。然而,在所有测试的条件下,基因组包装都受到严重损害。对细胞培养病毒后代的进一步分析表明,与野生型病毒不同,VP1 独特区(VP1u)部分暴露,并且在热处理后无法进一步外化。用于 VP1u 外化和基因组包装的五倍轴孔可能因非典型的 VP1u 构象而收缩,这解释了包装失败的原因。尽管 CD36+EPC 和缺氧促进了 B19V 的感染,但由于基因组包装失败,无法产生大量的感染性后代,这成为 B19V 体外繁殖的主要限制因素。

相似文献

1
Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.基因组包被受损限制了人细小病毒 B19 的体外增殖。
J Virol Methods. 2013 Oct;193(1):215-25. doi: 10.1016/j.jviromet.2013.06.003. Epub 2013 Jun 10.
2
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.体外生成的CD36+红系祖细胞对人细小病毒B19复制高度敏感。
J Virol. 2008 Mar;82(5):2470-6. doi: 10.1128/JVI.02247-07. Epub 2007 Dec 26.
3
Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.促红细胞生成素受体信号在人红系祖细胞细小病毒 B19 复制中的作用。
J Virol. 2010 Dec;84(23):12385-96. doi: 10.1128/JVI.01229-10. Epub 2010 Sep 22.
4
Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.低氧条件下原发性人红细胞祖细胞中有效细小病毒 B19 感染受 STAT5A 和 MEK 信号通路调控,但不受 HIFα调控。
PLoS Pathog. 2011 Jun;7(6):e1002088. doi: 10.1371/journal.ppat.1002088. Epub 2011 Jun 16.
5
Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.糖鞘脂 globoside 对于细小病毒 B19 进入细胞是可有可无的,但对于感染的有效进行是必不可少的。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00972-19. Print 2019 Oct 15.
6
Antiviral effect of cidofovir on parvovirus B19 replication.西多福韦对细小病毒 B19 复制的抗病毒作用。
Antiviral Res. 2015 Jan;113:11-8. doi: 10.1016/j.antiviral.2014.11.004. Epub 2014 Nov 13.
7
Parvovirus B19 integration into human CD36+ erythroid progenitor cells.细小病毒B19整合入人CD36⁺红系祖细胞。
Virology. 2017 Nov;511:40-48. doi: 10.1016/j.virol.2017.08.011. Epub 2017 Aug 12.
8
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.根据细胞周期状态增强对细小病毒 B19V 感染单位的基于细胞的检测。
Viruses. 2020 Dec 18;12(12):1467. doi: 10.3390/v12121467.
9
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.更昔洛韦增强延长暴露的红系祖细胞中细小病毒 B19 复制的抑制作用。
Virus Res. 2016 Jul 15;220:47-51. doi: 10.1016/j.virusres.2016.04.002. Epub 2016 Apr 9.
10
Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.细小病毒 B19 的摄取是一个高度选择性的过程,由 VP1u 控制,这是病毒嗜性的一个新决定因素。
J Virol. 2013 Dec;87(24):13161-7. doi: 10.1128/JVI.02548-13. Epub 2013 Sep 25.

引用本文的文献

1
Infectious parvovirus B19 circulates in the blood coated with active host protease inhibitors.感染性细小病毒 B19 存在于被主动宿主蛋白酶抑制剂包裹的血液中循环。
Nat Commun. 2024 Nov 5;15(1):9543. doi: 10.1038/s41467-024-53794-1.
2
Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood. parvovirus B19 DNA 可在扩张型心肌病患者的心脏中检测到,但在血液中不存在或不活跃。
ESC Heart Fail. 2021 Aug;8(4):2723-2730. doi: 10.1002/ehf2.13341. Epub 2021 May 1.
3
Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking.
人细小病毒 B19 在酸性条件下与Globoside 相互作用,作为内吞运输中的一个必要步骤。
PLoS Pathog. 2021 Apr 20;17(4):e1009434. doi: 10.1371/journal.ppat.1009434. eCollection 2021 Apr.
4
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.根据细胞周期状态增强对细小病毒 B19V 感染单位的基于细胞的检测。
Viruses. 2020 Dec 18;12(12):1467. doi: 10.3390/v12121467.
5
The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.人细小病毒 B19 的 VP1u:一种具有生物技术应用的多功能衣壳蛋白。
Viruses. 2020 Dec 18;12(12):1463. doi: 10.3390/v12121463.
6
Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.糖鞘脂 globoside 对于细小病毒 B19 进入细胞是可有可无的,但对于感染的有效进行是必不可少的。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00972-19. Print 2019 Oct 15.
7
Human Parvoviruses.人类细小病毒
Clin Microbiol Rev. 2017 Jan;30(1):43-113. doi: 10.1128/CMR.00040-16.
8
The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.VP1u受体将细小病毒B19的摄取限制在允许的红系细胞中。
Viruses. 2016 Sep 28;8(10):265. doi: 10.3390/v8100265.
9
The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.细小病毒B19的VP1u区域中的受体结合结构域。
Viruses. 2016 Feb 24;8(3):61. doi: 10.3390/v8030061.
10
Possible involvement of miRNAs in tropism of Parvovirus B19.微小RNA可能参与B19细小病毒的嗜性。
Mol Biol Rep. 2016 Mar;43(3):175-81. doi: 10.1007/s11033-016-3952-8. Epub 2016 Feb 15.